Hydroxamic Acids as PARP‐1 Inhibitors: Molecular Design and Anticancer Activity of Novel Phenanthridinones is a research paper published in Helvetica Chimica Acta (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Eesti Teadusagentuur
Grant: COVSG5
National Institutes of Health
Grant: R01GM139297
National Institutes of Health
Grant: R01 NS117000
National Institutes of Health
Grant: 1R01NS117000-01
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
National Institutes of Health
Grant: 5R01GM139297-04
Toward a deeper understanding of allostery and allotargeting by computational approaches
FWCI
0.58
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals